Modified risk tobacco product

Last updated

A brand of snus became the first FDA-approved MRTP, in 2019. Portioned snus.jpg
A brand of snus became the first FDA-approved MRTP, in 2019.

A modified risk tobacco product (MRTP) is a legal designation in the United States for a tobacco product that poses lower health risks to individual users and the population as a whole when compared to existing products on the market such as cigarettes (see health effects of tobacco). [1] The Family Smoking Prevention and Tobacco Control Act of 2009 gives the US Food and Drug Administration (FDA) broad authority to regulate tobacco products; the FDA's power extends to approving or rejecting MRTP applications.

Contents

Without approval from the FDA's Center for Tobacco Products, a tobacco company may not legally make reduced risk claims or change warning label statements. [2]

General Snus from Swedish Match became the first FDA-approved MRTP in October 2019; the designation is valid for five years. [3] In December 2021, the U.S. Food and Drug Administration (FDA) authorized the marketing of 22nd Century Group Inc.'s "VLN King" and "VLN Menthol King" combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. [4] These are the first combusted cigarettes to be authorized as MRTPs and the second tobacco products overall to receive "exposure modification" orders, which allows them to be marketed as having a reduced level of, or presenting a reduced exposure to, a substance. [4]

Applications accepted for review

An MRTP application submitted by smokeless tobacco maker Swedish Match in 2014 was the first ever accepted for review by the US FDA. [5]

Swedish Match sought approval to remove warnings about mouth cancer, gum disease, and tooth loss from packaging of eight of its General Snus products. The company also asked the US FDA to strike a statement reading "this product is not a safe alternative to cigarettes" as required by the Family Smoking Prevention and Tobacco Control Act. The company asked the US FDA to replace the statement with language acknowledging the harmful nature of all tobacco products and the reduced risk profile of Swedish snus by comparison. [5] In December 2016, the FDA initially rejected Swedish Match's application on the grounds that its snus were not actually safer than other smokeless tobacco products or cigarettes. [6] In October 2019, FDA finally approved the MRTP request for the product. [3]

The US FDA has also accepted applications from the R. J. Reynolds Tobacco Company for removing warnings from its Camel Snus product and from Philip Morris International for permission to market its heat-not-burn tobacco product iQOS as safer than a traditional cigarette. [7] iQOS was ultimately approved for sale in the United States using pre-market tobacco application method on April 30, 2019, which subjected it to marketing restrictions. [8]

The FDA, on December 23, 2021, approved an MRTP application from 22nd Century Group for their VLN King and VLN Menthol King very low nicotine cigarettes (VLNC). These cigarettes have up to 96% less nicotine than conventional cigarettes and help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second tobacco products overall to receive "exposure modification" orders, which allows them to be marketed as having a reduced level of, or presenting a reduced exposure to, a substance. [9]

Public FDA scientific advisory committee meetings

At the conclusion of public meetings hosted by the US FDA on April 9–10, 2015, the Tobacco Products Scientific Advisory Committee (TPSAC) voted against recommending a labeling change that would give Swedish Match's snus product a modified risk designation. The committee tied 4–4 in a yes or no vote when asked whether the snus product demonstrated substantially lower risk compared to cigarettes. [10] The panel's recommendations are not legally binding.

On January 25, 2018, the TPSAC rejected Philip Morris' claims that its iQOS heat-not-burn tobacco product was safer than a traditional cigarette. The committee voted 8–0 with one abstention to reject Philip Morris' claim that switching from cigarettes to iQOS can reduce the risks of tobacco-related disease and 5–4 to reject its claim that iQOS is less harmful than a traditional cigarette. However, it voted 8–1 to approve Philip Morris' claim that iQOS contains fewer harmful chemicals than a traditional cigarette. [11]

Related Research Articles

<span class="mw-page-title-main">Premier (cigarette)</span>

Premier was an American brand of smokeless cigarettes which was owned and manufactured by the R.J. Reynolds Tobacco Company (RJR). Premier was released in the United States in 1988. It was the first commercial heated tobacco product. However, it was difficult to use and tasted unpleasant; as a result, it was unpopular with consumers. A commercial failure, the brand was a significant financial loss for RJR and was quickly taken off the market.

<span class="mw-page-title-main">Snus</span> Moist tobacco product placed under the upper lip

Snus is a tobacco product, originating from a variant of dry snuff in early 18th-century Sweden. It is placed between the upper lip and gum for extended periods, as a form of sublabial administration. Snus is not fermented. Although used similarly to American dipping tobacco, snus does not typically result in the need for spitting, and, unlike naswar, snus is steam-pasteurized.

<span class="mw-page-title-main">Nicotine replacement therapy</span> Treatment for tobacco use disorder

Nicotine replacement therapy (NRT) is a medically approved way to treat people with tobacco use disorder by taking nicotine through means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting tobacco smoking by about 55%. Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of multiple types of NRT at a time may increase effectiveness.

Nicorette is the brand name of a number of products for nicotine replacement therapy (NRT) that contain nicotine polacrilex. Developed in the late 1970s in Sweden by AB Leo in the form of a chewing gum, Nicorette was the first nicotine replacement product on the market.

<span class="mw-page-title-main">Dipping tobacco</span> Finely ground smokeless tobacco product

Dipping tobacco is a type of finely ground or shredded, moistened smokeless tobacco product. It is commonly and idiomatically known as dip. Dipping tobacco is used by placing a pinch, or "dip", of tobacco between the lip and the gum. The act of using it is called dipping. Dipping tobacco is colloquially called chaw, snuff, rub, or fresh leaf among other terms; because of this, it is sometimes confused with other tobacco products—namely dry snuff.

<span class="mw-page-title-main">Smokeless tobacco</span> Tobacco product used by means other than smoking

Smokeless tobacco is a tobacco product that is used by means other than smoking. Their use involves chewing, sniffing, or placing the product between gum and the cheek or lip. Smokeless tobacco products are produced in various forms, such as chewing tobacco, snuff, snus, and dissolvable tobacco products. Smokeless tobacco products typically contain over 3000 constituents. Smokeless tobacco is widely used in South Asia and this accounts for about 80% of global consumption, as per WHO data. All smokeless tobacco products contain nicotine and are therefore highly addictive. Quitting smokeless tobacco use is as challenging as smoking cessation.

<span class="mw-page-title-main">Menthol cigarette</span> Cigarette flavored with the compound menthol

A menthol cigarette is a cigarette infused with the compound menthol which imparts a “minty” flavor to the smoke. Menthol also decreases irritant sensations from nicotine by desensitizing receptors, making smoking feel less harsh compared to regular cigarettes. Some studies have suggested that they are more addictive. Menthol cigarettes are just as hard to quit and are just as harmful as regular cigarettes.

Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the use of drugs. Tobacco smoking is widely acknowledged as a leading cause of illness and death, and reducing smoking is vital to public health.

<span class="mw-page-title-main">Electronic cigarette</span> Device that vaporizes a liquid nicotine solution for inhalation

An electronic cigarette (e-cigarette) or vape is a device that simulates tobacco smoking. It consists of an atomizer, a power source such as a battery, and a container such as a cartridge or tank. Instead of smoke, the user inhales vapor. As such, using an e-cigarette is often called "vaping". The atomizer is a heating element that vaporizes a liquid solution called e-liquid, which quickly cools into an aerosol of tiny droplets, vapor and air. The vapor mainly comprises propylene glycol and/or glycerin, usually with nicotine and flavoring. Its exact composition varies, and depends on several things including user behavior.

<span class="mw-page-title-main">Family Smoking Prevention and Tobacco Control Act</span>

The Family Smoking Prevention and Tobacco Control Act, is a federal statute in the United States that was signed into law by President Barack Obama on June 22, 2009. The Act gives the Food and Drug Administration the power to regulate the tobacco industry. A signature element of the law imposes new warnings and labels on tobacco packaging and their advertisements, with the goal of discouraging minors and young adults from smoking. The Act also bans flavored cigarettes, places limits on the advertising of tobacco products to minors and requires tobacco companies to seek FDA approval for new tobacco products.

Herbal smokeless tobacco is any product that imitates types of smokeless tobacco but does not contain tobacco and nicotine, or may contain nicotine without tobacco. Like herbal cigarettes and electronic cigarettes, they are often used as a tobacco cessation aid. Herbal smokeless tobacco use is an alternative to using smokeless tobacco that may help users quit.

Dissolvable tobacco is a tobacco product that dissolves in the mouth. Major tobacco manufacturers that sell dissolvable tobacco products include R. J. Reynolds Tobacco Company. Research into health effects of dissolvable and other new tobacco products was among the reasons of the establishment of the Tobacco Products Scientific Advisory Committee of the Food and Drug Administration in 2009.

<span class="mw-page-title-main">Youth smoking</span> Overview article

Smokingamong youth and adolescents is an issue that affects countries worldwide. While the extent to which smoking is viewed as a negative health behavior may vary across different nations, it remains an issue regardless of how it is perceived by different societies. The United States has taken numerous measures, ranging from changes in national policy surrounding youth cigarette access to changes in media campaigns, in attempts to eliminate the use of tobacco products among teenagers. Approximately 90% of smokers begin smoking prior to the age of 18.

<span class="mw-page-title-main">Regulation of tobacco by the U.S. Food and Drug Administration</span>

Regulation of tobacco by the U.S. Food and Drug Administration began in 2009 with the passage of the Family Smoking Prevention and Tobacco Control Act by the United States Congress. With this statute, the Food and Drug Administration (FDA) was given the ability to regulate tobacco products.

<span class="mw-page-title-main">Regulation of electronic cigarettes</span>

Regulation of electronic cigarettes varies across countries and states, ranging from no regulation to banning them entirely. As of 2015, around two thirds of major nations have regulated e-cigarettes in some way. A 2023 report by the World Health Organization (WHO) found that 34 countries had banned the sale of e-cigarettes.

The scientific community in the United States and Europe are primarily concerned with the possible effect of electronic cigarette use on public health. There is concern among public health experts that e-cigarettes could renormalize smoking, weaken measures to control tobacco, and serve as a gateway for smoking among youth. The public health community is divided over whether to support e-cigarettes, because their safety and efficacy for quitting smoking is unclear. Many in the public health community acknowledge the potential for their quitting smoking and decreasing harm benefits, but there remains a concern over their long-term safety and potential for a new era of users to get addicted to nicotine and then tobacco. There is concern among tobacco control academics and advocates that prevalent universal vaping "will bring its own distinct but as yet unknown health risks in the same way tobacco smoking did, as a result of chronic exposure", among other things.

A premarket tobacco application (PMTA) is an application that must be reviewed and approved by the Food and Drug Administration before a new tobacco product can be legally marketed in the United States. The first PMTA, and only to date, was approved by US FDA on November 10, 2015, when the FDA authorized the marketing of eight Swedish Match North America Inc. snus smokeless tobacco products.

A heated tobacco product (HTP) is a tobacco product that heats the tobacco at a lower temperature than conventional cigarettes. These products contain nicotine, which is a highly addictive chemical. The heat generates an aerosol or smoke to be inhaled from the tobacco, which contains nicotine and other chemicals. HTPs may also contain additives not found in tobacco, including flavoring chemicals. HTPs generally heat tobacco to temperatures under 600 °C (1100 °F), a lower temperature than conventional cigarettes.

<span class="mw-page-title-main">Nicotine pouch</span> Nicotine product

Nicotine pouches are white pouches usually made from plant fibers containing nicotine among other ingredients. They do not include tobacco leaf, dust, or stem. The nicotine may either be derived from tobacco plants or may be synthetic. Nicotine pouches are described as either similar to or a tobacco-free version of snus.

References

  1. "Modified Risk Tobacco Products - U.S. Food and Drug Administration". Tobacco Products.
  2. "Family Smoking Prevention and Tobacco Control Act". U.S. Food and Drug Administration (FDA). Retrieved May 19, 2015.
  3. 1 2 "FDA grants first-ever modified risk orders to eight smokeless tobacco products". U.S. Food and Drug Administration (FDA). October 22, 2019. Retrieved May 6, 2020.
  4. 1 2 "FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them". U.S. Food and Drug Administration (FDA) (Press release). December 23, 2021. Retrieved December 26, 2021.PD-icon.svg This article incorporates text from this source, which is in the public domain .
  5. 1 2 Tavernise, Sabrina (April 8, 2015). "Swedish Company Asks F.D.A. to Remove Warnings From Smokeless Tobacco Product". The New York Times. Retrieved May 19, 2015.
  6. Choiniere, Conrad (December 14, 2016). Modified Risk Tobacco Product (MRTP) Application Technical Project Lead (TPL) Review (PDF) (Technical report). FDA Center for Tobacco Products. MR0000020 -MR0000022, MR0000024-MR0000025, MR0000027-MR0000029.
  7. "Modified Risk Tobacco Products". U.S. Food and Drug Administration. January 22, 2018. Retrieved April 27, 2018.
  8. "FDA permits sale of IQOS Tobacco Heating System through premarket tobacco product application pathway". Food and Drug Administration. April 30, 2019.
  9. Commissioner, Office of the (December 23, 2021). "FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them". FDA. Retrieved December 25, 2021.
  10. Tavernise, Sabrina (April 11, 2015). "Milder Warning Opposed for Swedish Tobacco Item". The New York Times. Retrieved May 19, 2015.
  11. Page, Barnaby (January 25, 2018). "FDA committee rejects two IQOS MRTP claims, approves one". ECig Intelligence. Retrieved April 27, 2018.